References
2. Centers for Disease Control and Prevention (CDC). Intensive-care patients with severe novel influenza A (H1N1) virus infection-Michigan, June 2009.
MMWR Morb Mortal Wkly Rep 2009;58:749–52. Available at:
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5827a4.htm. Accessed July 17, 2009.
3. Australia and New Zealand Extracorporeal Membrane Oxygenation (ANZ ECMO) Influenza Investigators; Davies A, Jones D, Bailey M, et al. Extracorporeal membrane oxygenation for 2009 influenza A(H1N1) acute respiratory distress syndrome. JAMA 2009;302:1888–1895.
4. Saleeby E, Chapman J, Morse J, et al. H1N1 Influenza in pregnancy: cause for concern. Obstet Gynecol 2009;114:885–891.
5. Van Wissen M, Keller TT, Ronkes B, et al. Influenza infection and risk of acute pulmonary embolism.Thromb J 2007;5:16.
6. Mauad T, Hajjar LA, Callegari GD, et al. Lung pathology in fatal novel human influenza A (H1N1) infection. Am J Respir Crit Care Med 2010;181:72–79.
7. Morens DM, Taubenberger JK, Fauci AS. Prominent role of bacterial pneumonia as a cause of death in pandemic influenza: implications for pandemic influenza preparedness. J Infect Dis. 2008;198:962–970.
8. Ruest A, Michaud S, Deslandes S, et al. Comparison of the Directigen flu A+B test, the QuickVue influenza test, and clinical case definition to viral culture and reverse transcription-PCR for rapid diagnosis of influenza virus infection. J Clin Microbiol 2003;41:3487–3493.
9. Uyeki TM, Prasad R, Vukotich C, et al. Low sensitivity of rapid diagnostic test for influenza. Clin Infect Dis 2009;48:e89–e92.
10. Rello J, Rodríguez A, Ibañez P, et al; H1N1 SEMICYUC Working Group. Intensive care adult patients with severe respiratory failure caused by influenza A (H1N1)v in Spain. Crit Care 2009;13:R148.
11. Uyeki T. Diagnostic testing for 2009 pandemic influenza A (H1N1) virus infection in hospitalized patients. N Engl J Med 2009;361:e114.
13. Ward P, Small I, Smith J, et al. Oseltamivir (Tamiflu) and its potential for use in the event of an influenza pandemic. J Antimicrob Chemother 2005;55 suppl:i5–i21.
14. Centers for Disease Control and Prevention. Oseltamivir-Resistant 2009 Pandemic Influenza A (H1N1) Virus Infection in Two Summer Campers Receiving Prophylaxis—North Carolina, 2009. Available at:
http://www.cdc.gov/mmwr/preview/mmwrhtml/mm5835a1.htm. Accessed September 11, 2009.
15. Meduri GU, Golden E, Freire AX, et al. Methylprednisolone infusion in early severe ARDS: results of a randomized controlled trial. Chest 2007;131:954–963.
16. Steinberg KP, Hudson LD, Goodman RB, et al; National Heart, Lung, and Blood Institute Acute Respiratory Distress Syndrome (ARDS) Clinical Trials Network. Efficacy and safety of corticosteroids for persistent acute respiratory distress syndrome. N Engl J Med 2006;354:1671–1684.
17. Quispe-Laime AM, Bracco JD, Barberio PA, et al. H1N1 influenza A virus-associated acute lung injury: response to combination oseltamivir and prolonged corticosteroid treatment. Intensive Care Med2010:36:33–41.
20. Guerin C, Gaillard S, Lemasson S, et al. Effects of systematic prone positioning in hypoxemic acute respiratory failure: a randomized controlled trial. JAMA 2004;292:2379–2387.
21. Gattinoni L, Tognoni G, Pesenti A, et al; Prone-Supine Study Group. Effect of prone positioning on the survival of patients with acute respiratory failure. N Engl J Med 2001;345:568–573.
22. Zapol WM, Snider MT, Hill JD, et al. Extracorporeal membrane oxygenation in severe acute respiratory failure. A randomized prospective study. JAMA 1979;242:2193–2196.
23. Plotkin JS, Shah JB, Lofland GK, et al. Extracorporeal membrane oxygenation in the successful treatment of traumatic adult respiratory distress syndrome: case report and review. J Trauma 1994;37:127–130.
24. Morton A, Dalton H, Kochanek P, et al. Extracorporeal membrane oxygenation for pediatric respiratory failure: five-year experience at the University of Pittsburgh. Crit Care Med 1994;22:1659–1667.
25. Zwischenberger JB, Conrad SA, Alpard SK, et al. Percutaneous extracorporeal arteriovenous CO2 removal for severe respiratory failure. Ann Thorac Surg 1999;68:181–187.
26. Parcevaux M, Antok E, Boisson V, et al. Acute respiratory distress due to Influenza A (H1N1) S-OIV and extracorporeal oxygenation: the benefit of a multidisciplinary care network [in French]. Ann Fr Anesth Reanim 2010;29:145–148.
27. Freed DH, Henzler D, White CW, et al; Canadian Critical Care Trials Group. Extracorporeal lung support for patients who had severe respiratory failure secondary to influenza A (H1N1) 2009 infection in Canada. Can J Anaesth 2010;57:240–247.